Endoscopic Retrograde Cholangiopancreatography/ERCP Market is expected to surge at a USD 2.9 billion by 2031 | Boston Scientific Corporation (US)
The global endoscopic retrograde cholangiopancreatography was valued at USD 1.5 billion in 2021 and it is anticipated to grow up to USD 2.9 billion by …